"A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel\u2011Group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma\u00AE 5% DIF in Patients With Post-Polio Syndrome"@en . . . .